[{"orgOrder":0,"company":"Nordic Biotic Sp. z o.o.","sponsor":"Medical University of Lublin","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"POLAND","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Bifidobacterium Lactis","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Nordic Biotic Sp. z o.o.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nordic Biotic Sp. z o.o. \/ Medical University of Lublin","highestDevelopmentStatusID":"1","companyTruncated":"Nordic Biotic Sp. z o.o. \/ Medical University of Lublin"},{"orgOrder":0,"company":"Aker BioMarine","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"NORWAY","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Bifidobacterium Lactis","moa":"||Gut microbiome","graph1":"Nutrition and Weight Loss","graph2":"Approved FDF","graph3":"Aker BioMarine","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Capsule, Delayed Release","sponsorNew":"Aker BioMarine \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Aker BioMarine \/ Undisclosed"},{"orgOrder":0,"company":"Bioma Health","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"LITHUANIA","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Lactobacillus Acidophilus","moa":"||Gut Microbiome","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Bioma Health","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Bioma Health \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bioma Health \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Bifidobacterium Lactis

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          FNCE
                          Not Confirmed
                          FNCE
                          Not Confirmed

                          Details : Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion naturally.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          August 05, 2025

                          Lead Product(s) : Bifidobacterium Lactis,Lactobacillus Gasseri,Lactobacillus Rhamnosus

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          FNCE
                          Not Confirmed
                          FNCE
                          Not Confirmed

                          Details : Bioma Probiotics is a potent blend of prebiotics, probiotics, and postbiotics to help nourish the gut, reduce bloating, enhance energy, and support weight management.

                          Product Name : Bioma Probiotics

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          June 23, 2025

                          Lead Product(s) : Lactobacillus Acidophilus,Bifidobacterium Lactis,Saccharomyces Boulardii

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Nordic Biotic Sp. z o.o.

                          Country arrow
                          FNCE
                          Not Confirmed

                          Nordic Biotic Sp. z o.o.

                          Country arrow
                          FNCE
                          Not Confirmed

                          Details : Bifidobacterium lactis is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          October 01, 2021

                          Lead Product(s) : Bifidobacterium Lactis

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Medical University of Lublin

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank